Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg
L Stump

Showing results (81-90 of 392) with videos related to

Pageof 40
Sort By:
Biology|April 13, 2026
The Result Is Clear: Color Trap Preferences of Adult Necrophagous FliesAidan E Bonn, Karielly L Castaneda, Clara L Stump, et al.
Gastro Hep Advances|September 16, 2024
Lower Incidence of HCC and Other Major Adverse Liver Outcomes in People Living With HIV and Chronic Liver DiseaseMaurice Michel, Hannes Hagström, Linnea Widman, et al.
United European Gastroenterology Journal|July 24, 2020
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney diseaseLeonard Kaps, Christian Labenz, Peter R Galle, et al.
The American Journal of Gastroenterology|March 19, 2024
Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver DiseaseEmma Vanderschueren, Angelo Armandi, Wilhelmus Kwanten, et al.
Zeitschrift Fur Gastroenterologie|July 13, 2017
Epidemiology of hepatic encephalopathy in german hospitals - the EpHE studyChristian Labenz, Marcus-Alexander Wörns, Jörn M Schattenberg, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2020
Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitisNigel Cook, Andreas Geier, Andreas Schmid, et al.
Digestive Diseases and Sciences|December 5, 2019
Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in GermanyChristian Labenz, Yvonne Huber, Maurice Michel, et al.
Hepatology (Baltimore, Md.)|October 30, 2018
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic SteatohepatitisGeoff Farrell, Jörn M Schattenberg, Isabelle Leclercq, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2020
Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based studyChristian Labenz, Marcus-Alexander Wörns, Charles C Adarkwah, et al.
Frontiers in Medicine|May 21, 2019
The Patient Perspectives on Future Therapeutic Options in NASH and Patient NeedsNigel Cook, Andreas Geier, Andreas Schmid, et al.
Pageof 40

Showing results (81-90 of 392) with videos related to

Sort By:
Pageof 40
Biology|April 13, 2026
The Result Is Clear: Color Trap Preferences of Adult Necrophagous FliesAidan E Bonn, Karielly L Castaneda, Clara L Stump, et al.
Gastro Hep Advances|September 16, 2024
Lower Incidence of HCC and Other Major Adverse Liver Outcomes in People Living With HIV and Chronic Liver DiseaseMaurice Michel, Hannes Hagström, Linnea Widman, et al.
United European Gastroenterology Journal|July 24, 2020
Non-alcoholic fatty liver disease increases the risk of incident chronic kidney diseaseLeonard Kaps, Christian Labenz, Peter R Galle, et al.
The American Journal of Gastroenterology|March 19, 2024
Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver DiseaseEmma Vanderschueren, Angelo Armandi, Wilhelmus Kwanten, et al.
Zeitschrift Fur Gastroenterologie|July 13, 2017
Epidemiology of hepatic encephalopathy in german hospitals - the EpHE studyChristian Labenz, Marcus-Alexander Wörns, Jörn M Schattenberg, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2020
Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitisNigel Cook, Andreas Geier, Andreas Schmid, et al.
Digestive Diseases and Sciences|December 5, 2019
Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in GermanyChristian Labenz, Yvonne Huber, Maurice Michel, et al.
Hepatology (Baltimore, Md.)|October 30, 2018
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic SteatohepatitisGeoff Farrell, Jörn M Schattenberg, Isabelle Leclercq, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2020
Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based studyChristian Labenz, Marcus-Alexander Wörns, Charles C Adarkwah, et al.
Frontiers in Medicine|May 21, 2019
The Patient Perspectives on Future Therapeutic Options in NASH and Patient NeedsNigel Cook, Andreas Geier, Andreas Schmid, et al.
Pageof 40